Clinical Features of Influenza C Virus Infection in Children

Matsuzaki, Yoko; Katsushima, Noriko; Nagai, Yukio; Shoji, Makoto; Itagaki, Tsutomu; Sakamoto, Michiyo; Kitaoka, Setsuko; Mizuta, Katsumi; Nishimura, Hidekazu
May 2006
Journal of Infectious Diseases;5/1/2006, Vol. 193 Issue 9, p1229
Academic Journal
Background. Seroepidemiological studies have revealed that influenza C virus is widely distributed globally. However, because the isolation of this virus is difficult, there have been few reports on its clinical features. Methods. Between December 1990 and November 2004, 84,946 respiratory-tract specimens were obtained from patients ⩽15 years old. On the basis of the results of isolation of virus, we examined the clinical data on children infected with influenza C virus. Results. Of 170 children infected with influenza C virus, 157 (92.4%) were <6 years old. Fever (frequency, 90.0%), cough (frequency, 74.1%), and rhinorrhea (frequency, 61.8%) were the most frequent symptoms. The mean duration of fever was 2.88 days (standard deviation, 1.66 days). Of the 170 children, 29 were hospitalized, and 21 (72.4%) of these 29 had lower-respiratory-tract illness such as pneumonia, bronchitis, and bronchiolitis. The rate of hospital admission was significantly higher in children <2 years old than in children 2-5 years old (30.4% vs. 11.9%; P=.0043). Conclusions. Influenza C virus is a significant cause of upper-respiratory-tract illness in children <6 years old, and the risk of complications with lower-respiratory-tract illness is particularly high in children <2 years old.


Related Articles

  • STUDIES IN EXPERIMENTAL IMMUNOLOGY OF INFLUENZA I. THE STATE OF VIRUS RECEPTORS AND INHIBITORS IN THE RESPIRATORY TRACT. De St. Groth, S. Fazekas // Australian Journal of Experimental Biology & Medical Science;Jan1950, Vol. 28 Issue 1, p15 

    Investigates the separate mechanisms possibly involved in infection by and resistance to influenza viruses. Response of mice to influenza virus; State of respiratory receptors after infection; Assessment of respiratory inhibitors after vaccination; Virus content of lungs and bronchial washings...

  • Update: Influenza Activity -- United States, January 18-24, 2004.  // MMWR: Morbidity & Mortality Weekly Report;1/30/2004, Vol. 53 Issue 3, p63 

    Provides an update on the influenza activity in the U.S. in the week of January 18-24, 2004. Results of the laboratory surveillance of influenza activity; Number of deaths from pneumonia and influenza; Number of U.S. states that reported influenza activity.

  • Influenza vaccine helps protect you. Lazorik, Donna // Massachusetts Nurse;Oct2004, Vol. 75 Issue 8, p8 

    This article focuses on the use of influenza vaccine. Every year in Massachusetts, an estimated 2,600 people are hospitalized and 800 people die due to complications from influenza, a highly infectious viral disease. Because of their increased exposure to people who are ill, nurses, like other...

  • Respiratory Viral Infections in Patients With COPD Exacerbation. Hosseini, Seyedeh Somayeh; Jamaati, Hamidreza; Roodbari, Fatemeh; Emamzadegan, Behzad // HealthMed;2012, Vol. 6 Issue 2, p360 

    Background: There is growing evidence that viral infections play a role as a risk factor for COPD exacerbation. This study aimed at epidemiological evaluation of viral respiratory infections in patients COPD exacerbation. Materials and Methods: In this descriptive cross-sectional study...

  • Human infection with new influenza A (H1N1) virus: Mexico, update, March--May 2009.  // Weekly Epidemiological Record;6/5/2009, Vol. 84 Issue 23, p213 

    The article reports on the updates for human infection with new influenza A (H1N1) virus for March-May 2009 in Mexico. It states that there has been an outbreak of acte respiratory infections and there have been notification of a rapidly progressive severe pneumonia in the metropolitan of Mexico...

  • Acute Bronchitis. Wenzel, Richard P.; Fowler, Alpha A. // New England Journal of Medicine;11/16/2006, Vol. 355 Issue 20, p2125 

    This article discusses the diagnosis and treatment of patients with acute bronchitis. A case study is presented and the course of the disease along with the likely viral and bacterial causes are described. The disease is differentiated from asthma or bronchiolitis and bronchiectasis. The author...

  • Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Shinya, K.; Shimada, A.; Ito, T.; Otsuki, K.; Morita, T.; Tanaka, H.; Takada, A.; Kida, H.; Umemura, T. // Archives of Virology;Jan2000, Vol. 145 Issue 1, p187 

    Summary. To define the route of influenza virus invasion into the central nervous system (CNS), an avian influenza A (H5N3) virus was inoculated into mice intranasally or intravenously. Only the intranasal infection group mice showed depression and retention of gas in the digestive system....

  • Secondary bacterial pneumonia due to Staphylococcus aureus complicating 2009 influenza A (H1N1) viral infection. Tsigrelis, C.; Mohammad, M.; Fraimow, H. S.; Dellinger, R. P.; Marchesani, D.; Reboli, A. C. // Infection;Jun2010, Vol. 38 Issue 3, p237 

    The article discusses two patients with influenza A (H1N1) viral infection complicated with the onset of secondary bacterial pneumonia due to Staphylococcus aureus in the U.S. It outlines the diagnostic examinations undertaken by the patients to determine the proper treatment of their condition....

  • Transmissibility of 1918 pandemic influenza. Mills, Christina E.; Robins, James M.; Lipsitch, Marc // Nature;12/16/2004, Vol. 432 Issue 7019, p904 

    The 1918 influenza pandemic killed 20-40 million people worldwide, and is seen as a worst-case scenario for pandemic planning. Like other pandemic influenza strains, the 1918 A/H1N1 strain spread extremely rapidly. A measure of transmissibility and of the stringency of control measures required...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics